GGS vs Cepheid?

If you read the AGM presentation from 2018, the CEO discusses GSS tests in comparison to some leading competitors including Cepheid on page 20. You're right the Cepheid tests are more targeted. They are also more expensive and not suited so much to higher throughput. Cepheid are doing v well but fill a slightly different niche to GSS (Cepheid are more toward the 'point of care' market) and I would be surprised if the labs you mention use Cepheid solely. In my experience Cepheid tests are used alongside other tests like the ones of GSS designed for wider screening and higher throughput (more cost effective and detect more pathogens). There are other competitors in this space eg Seegene but none use the 3 base technology of GSS which gives the tests wider and more reliable detection. The very fact GSS sales are doing so well in a competitive market suggest they do indeed have an advantage. I see from recent full year report we are starting to see sales in UK. Fingers crossed its a matter of time till major OS contract.
The major contract in Australia is with Australian Clinical Laboratories.

Thanks for your reply. You are right, most labs run Genexpert as "preliminary" test and also run traditional method.
I'm glad I stumbled upon this company, I think even at current valuation it looks to be quite cheap.
GLTYA